Inventiva

News

UK's Claret Capital raises €575m for European biotechs

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

News

AbbVie sheds autoimmune disease drug in blow to partner Inve...

Shares in French biotech Inventiva were on the slide this morning after AbbVie revealed that it had decided to abandon development of cedirogant, their drug candidate for autoimmune disease

News

The liver is a vital organ of the digestive system present in vertebrates and some other animals. It has a wide range of functions, including detoxification, protein synthesis, and production of biochemicals necessary for digestion.

High hopes as Inventiva takes NASH contender into phase 3

Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, as the company prepares for the launch of a phase 3 trial in s

News

Analysts tip Inventiva's lanifibranor as NASH blockbuster

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals i

News

Boehringer to develop fibrosis treatment with Inventiva

Boehringer to progress R&D partnership that began last year

UK's Claret Capital raises €575m for European biotechs

AbbVie sheds autoimmune disease drug in blow to partner Inve...

High hopes as Inventiva takes NASH contender into phase 3

Analysts tip Inventiva's lanifibranor as NASH blockbuster

Boehringer to develop fibrosis treatment with Inventiva

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Inventiva

Editor's Picks